Rapid in-country sequencing of whole virus genomes to inform rabies elimination programmes
-
Published:2020-01-07
Issue:
Volume:5
Page:3
-
ISSN:2398-502X
-
Container-title:Wellcome Open Research
-
language:en
-
Short-container-title:Wellcome Open Res
Author:
Brunker KirstynORCID, Jaswant Gurdeep, Thumbi S.M.ORCID, Lushasi KennedyORCID, Lugelo Ahmed, Czupryna Anna M., Ade Fred, Wambura GatiORCID, Chuchu Veronicah, Steenson RachelORCID, Ngeleja Chanasa, Bautista Criselda, Manalo Daria L.ORCID, Gomez Ma. Ricci R., Chu Maria Yna Joyce V.ORCID, Miranda Mary Elizabeth, Kamat MayaORCID, Rysava KristynaORCID, Espineda Jason, Silo Eva Angelica V., Aringo Ariane Mae, Bernales Rona P., Adonay Florencio F., Tildesley Michael J.ORCID, Marston Denise A., Jennings Daisy L., Fooks Anthony R.ORCID, Zhu Wenlong, Meredith Luke W.ORCID, Hill Sarah C., Poplawski Radoslaw, Gifford Robert J.ORCID, Singer Joshua B.ORCID, Maturi Mathew, Mwatondo Athman, Biek RomanORCID, Hampson Katie
Abstract
Genomic surveillance is an important aspect of contemporary disease management but has yet to be used routinely to monitor endemic disease transmission and control in low- and middle-income countries. Rabies is an almost invariably fatal viral disease that causes a large public health and economic burden in Asia and Africa, despite being entirely vaccine preventable. With policy efforts now directed towards achieving a global goal of zero dog-mediated human rabies deaths by 2030, establishing effective surveillance tools is critical. Genomic data can provide important and unique insights into rabies spread and persistence that can direct control efforts. However, capacity for genomic research in low- and middle-income countries is held back by limited laboratory infrastructure, cost, supply chains and other logistical challenges. Here we present and validate an end-to-end workflow to facilitate affordable whole genome sequencing for rabies surveillance utilising nanopore technology. We used this workflow in Kenya, Tanzania and the Philippines to generate rabies virus genomes in two to three days, reducing costs to approximately £60 per genome. This is over half the cost of metagenomic sequencing previously conducted for Tanzanian samples, which involved exporting samples to the UK and a three- to six-month lag time. Ongoing optimization of workflows are likely to reduce these costs further. We also present tools to support routine whole genome sequencing and interpretation for genomic surveillance. Moreover, combined with training workshops to empower scientists in-country, we show that local sequencing capacity can be readily established and sustainable, negating the common misperception that cutting-edge genomic research can only be conducted in high resource laboratories. More generally, we argue that the capacity to harness genomic data is a game-changer for endemic disease surveillance and should precipitate a new wave of researchers from low- and middle-income countries.
Funder
Scottish Government New Partnership for Africa's Development Department for International Development, UK Government Royal Society of Tropical Medicine and Hygiene Department for Environment, Food and Rural Affairs Wellcome Trust African Academy of Sciences Scottish Funding Council UK Research and Innovation
Publisher
F1000 Research Ltd
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|